CATAPULT GROUP INTERNATIONAL LIMITED (CAT)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
CAT - CATAPULT GROUP INTERNATIONAL LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: March
GICS Industry Group : Technology Hardware & Equipment
Index: ALL-ORDS | ALL-TECH
FNArena Sector : Medical Equipment & Devices
Year End: March
Catapult Group develops and sells wearable sensors to monitor and analyse athletic performance, including fitness and skill levels, injury risks and rehabilitation assistance. It listed on the ASX in 2014.
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$1.07
16 May |
0.000 OPEN $1.10 |
0.000 HIGH $1.13 |
341,592 LOW $1.05 |
| TARGET | |||||
|
|||||
| OTHER COMPANIES IN THE SAME SECTOR | |||
| ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . VHT . ONE . IDX . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . AT1 . CBL . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
| Title | FY22 Forecast |
FY23 Forecast |
|---|---|---|
| EPS (cps) | - 0.9 | xxx |
| DPS (cps) | 0.0 | xxx |
| EPS Growth | N/A | xxx |
| DPS Growth | N/A | xxx |
| PE Ratio | N/A | xxx |
| Dividend Yield | 0.0% | xxx |
| Div Pay Ratio(%) | N/A | xxx |
All estimates have been converted into AUD by FNArena at present FX values.
Dividend yield today if purchased 3 years ago: 0.00%
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
| Title | 2016 | 2017 | 2018 | 2019 | 2021 |
|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | -8.5 |
| DPS All | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | 93.1 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | 52.5 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | 19.6 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | -17.58 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2016 | 2017 | 2018 | 2019 | 2021 |
|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | -14.77 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | -14.54 % |
| Return on Assets | xxx | xxx | xxx | xxx | -9.73 % |
| Return on Equity | xxx | xxx | xxx | xxx | -14.77 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | -13.78 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | 17.1 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
CAT STOCK CHART
FNArena News on CAT
| 1 |
Rudi’s View: Peter’s Portfolio ReviewedApr 13 2022 - Rudi's View |
| 2 |
Australian Broker Call *Extra* Edition – Nov 25, 2021Nov 25 2021 - Daily Market Reports |
| 3 |
Next Week At A Glance – 15-19 Nov 2021Nov 12 2021 - Weekly Reports |
| 4 |
Rudi’s View: Adairs, Gentrack, ReadyTech, Macquarie, Qantas And NufarmOct 21 2021 - Rudi's View |
| 5 |
Rudi’s View: Telstra, Iress, NextDC And That Grand DelusionSep 23 2021 - Rudi's View |
Latest Medical Equipment & Devices News
| 1 |
Shortages Chip Away At ResMed’s Big BreakMar 30 2022 - Australia |
| 2 |
Opportunity for Fisher & Paykel HealthcareMar 25 2022 - Australia |
| 3 |
Distribution Anxiety For NanosonicsFeb 10 2022 - Australia |
| 4 |
Brokers Awake To ResMed’s PotentialJan 31 2022 - Australia |
| 5 |
Covid Benefits F&P Healthcare, For NowDec 06 2021 - Australia |
| 6 |
Will Shortages Limit Upside For ResMed?Nov 01 2021 - Australia |
| 7 |
Nanosonics Unveils Its New ProductAug 26 2021 - Australia |
| 8 |
Pro Medicus: Opportunity AwaitsAug 24 2021 - Technicals |
| 9 |
Breakout For CochlearAug 10 2021 - Technicals |
| 10 |
Will ResMed’s Market Share Gains Last?Aug 09 2021 - Australia |